Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;3(3):e94.
doi: 10.1371/journal.pmed.0030094. Epub 2006 Feb 21.

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge

Edward Mills  1 , Stephanie Nixon, Sonal Singh, Sonam Dolma, Anjali Nayyar, Sushma Kapoor
Affiliations

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge

Edward Mills et al. PLoS Med. 2006 Mar.

Abstract

Mills and colleagues argue that the challenge of enrolling women into HIV vaccine trials must be overcome in order for trials to be considered ethical, valid, and generalizable.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors declare that no competing interests exist.

Figures

Figure 1
Figure 1. HIV Vaccine Awareness Day at the AIDS Community Health Initiative Enroute to a Vaccine Effort (Project ACHIEVE), 18 May 2005
(Photo: Project ACHIEVE)
See this image and copyright information in PMC

References

    1. The Joint United Nations Programme on HIV/AIDS [UNAIDS] Global summary of the HIV and AIDS epidemic, December 2005. Geneva: NAIDS; 2005. Available: http://www.unaids.org/en/resources/epidemiology/epicore.asp. Accessed 8 December 2005 .
    1. Kapoor S. Gender in AIDS vaccine trials. Addressing challenges in developing countries. New York: International AIDS Vaccine Initiative 2004; 2004. Available: http://www.iavi.org/file.cfm?fid=398. Accessed 8 January 2006.
    1. Newman PA, Duan N, Lee SJ, Rudy ET, Seiden DS, et al. HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics. 2005 Vaccine: E-pub ahead of print. - PMC - PubMed
    1. Newman PA, Duan N, Rudy ET, Anton PA. Challenges for HIV vaccine dissemination and clinical trial recruitment: If we build it, will they come? AIDS Patient Care STDS. 2004;18:691–701. - PubMed
    1. Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: Concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37:1393–1403. - PubMed

Publication types